Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
Seong Ran Jeon
Intest Res. 2018;16(2):163-165. Published online 2018 Apr 30 DOI: https://doi.org/10.5217/ir.2018.16.2.163
Citations to this article as recorded by
Inflammatory Bowel Disease – Non-biological treatment
Fernando Magro, Gonçalo Cordeiro, Andreia Martins Dias, Maria Manuela Estevinho
Pharmacological Research.2020; 160: 105075. CrossRef